SPL

Why did SPL fall 6.0% on 29 Apr 2026?

Starpharma · Pharmaceuticals, Biotechnology & Life Sciences

−6.00%1.9× normal volumeUnknownHistorical estimate

What moved it

No direct company-specific news explains the drop; likely broad sector or market flow given the generic nature of surrounding articles.

The supplied news articles do not mention Starpharma Holdings or any event that would directly affect its stock. The articles are mostly generic market summaries or about other companies. The price drop could be due to an unannounced event or sector movement not captured in the provided news.

Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice.

The evidence

In the news

  • ASX Growth Companies With High Insider Ownership In April 2026

    finance.yahoo.com · 29 Apr 2026

  • Finder Energy Launches A$30m Equity Raise to Fast-Track KTJ Project

    smallcaps.com.au · 29 Apr 2026

  • NH3 Clean Energy Strengthens Financing Case with Strong Public Benefits Forecast for WAH2 Clean Ammonia Project

    smallcaps.com.au · 30 Apr 2026

  • ASX Growth Leaders With High Insider Ownership To Watch

    finance.yahoo.com · 30 Apr 2026

The 4 most recent of 8 articles read. Headlines link to the publisher.

Held by no ETF

Not currently held by any ETF we track.

Keep going

How is the site working for you?